The purpose of this course is to review the landscape and challenges of essential cancer medicine access, especially in developing countries, and delve into a methodology for evaluating medicine availability and approaches to mitigating drug stock-outs. The course will take a holistic evaluation of barriers/issues around cancer medicine access, including factors unrelated to price, and will focus on potential solutions to mitigating the various challenges around access.
The following audience would particularly benefit from this course:
After completion of the course participants will be able to understand:
|May - June 2020||Applications open|
|15-30 June 2020||Review of applications and notification of selected participants|
|July - October 2020||Master course delivery|
Title: Assistant Professor of Medicine
Organisation: University of Pennsylvania
Dr. Martei is a medical oncologist and clinical epidemiologist holding faculty positions at the University of Pennsylvania (Penn) and the University of Botswana. She is also a global health scholar at the Penn Center for Global Health. Her primary research focus is on evaluating and implementing strategies for high quality guideline-concordant therapy delivery in breast cancer patients in Sub Saharan Africa. Under this umbrella she has led research and published on access to essential cancer medicines and impact on therapy delivery with a focus on Botswana. She’s served on international panels evaluating cancer medicines access, including UICC Taskforce for the selection of essential cancer medicines and is currently a member of the Scientific Advisory Panel for the Medicines Patent Pool.
Title: Senior Advocacy Manager
Organisation: Union for International Cancer Control (UICC)
Shalini is the focal point for the work on access to treatment in UICC. She is a biologist by training and has extensive experience on the issues of access to quality assured medicines. She gained experience on this topic by working on the WHO Model List of Essential Medicines with the World Health Organization, MSF’s Access Campaign in India and other NGOs at international and national level. She also has experience working with the pharmaceutical industry.